Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen

Radiotherapy and Oncology

Volumn 70, Issue 3, 2004, Pages 301-309

  Horsman, Michael R ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C3H mouse mammary carcinoma; Carbogen; Nicotinamide; Radiation

Indexed keywords

CARBOGEN; CARBON DIOXIDE; NICOTINAMIDE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; BREATHING; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CHI SQUARE TEST; CONTROLLED STUDY; DESQUAMATION; ELECTRODE; FEMALE; GAS; HINDLIMB; IMMOBILIZATION; MEASUREMENT; METHODOLOGY; MOISTURE; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SKIN; TIME; TISSUE;

ANIMALS; CARBON DIOXIDE; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NIACINAMIDE; OXYGEN; PARTIAL PRESSURE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 1942439092     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.01.017     Document Type: Article

References (51)

1. Bergsjø P., Evans J.C. Tissue oxygen tension of cervix cancer: comparison of effects of breathing a carbon dioxide mixture and pure oxygen. Acta Radiol Ther Phys Biol. 7:1968;1-11.
2. Brown J.M. Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br J Cancer. 52:1979;650-656.
3. Bussink J., Stratford M.R.L., van der Kogel A.J., Folkes L.K., Kaanders J.H.A.M. Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy. Radiother Oncol. 63:2002;285-291.
4. Chaplin D.J., Durand R.E., Olive P.L. Acute hypoxia in tumors: implication for modifiers of radiation effects. Int J Radiat Oncol Biol Phys. 12:1986;1279-1282.
5. Chaplin D.J., Horsman M.R., Aoki D. Nicotinamide, fluosol DA and carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer. 63:1991;109-113.
6. Chaplin D.J., Horsman M.R., Siemann D.W. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. Br J Cancer. 68:1993;269-273.
7. Chaplin D.J., Horsman M.R., Trotter M.J. The effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J Natl Cancer Inst. 82:1990;672-676.
8. DeSault L.A. The effect of oxygen on the response of spontaneous tumors in mice to radiotherapy. Br J Radiol. 36:1963;749-754.
9. 2 histography. Br J Cancer. 66:1992;919-924.
10. Grau C., Horsman M.R., Overgaard J. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. Int J Radiat Oncol Biol Phys. 22:1992;415-419.
11. 2 by perfluorochemicals and carbogen. Int J Radiat Oncol Biol Phys. 13:1987;569-574.
12. Hendry J.H. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses. Int J Radiat Oncol Biol Phys. 5:1979;971-976.
13. Hendry J.H., Sutton M.L. Care with radiosensitizers. Br J Radiol. 51:1978;927-928.
14. 2, microcirculatory function and radiosensitivity. Int J Radiat Oncol Biol Phys. 40:1998;943-951.
15. Horsman M.R. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncol. 34:1995;571-587.
16. Horsman M.R. Measurement of tumour oxygenation. Int J Radiat Oncol Biol Phys. 42:1998;701-704.
17. Horsman M.R., Chaplin D.J., Overgaard J. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically hypoxic cells. Cancer Res. 50:1990;7430-7436.
18. Horsman M.R., Høyer M., Honess D.J., Dennis I.F., Overgaard J. Nicotinamide pharmacokinetics in humans and mice: ac omparative assessment and the implications for radiotherapy. Radiother Oncol. 27:1993;131-139.
19. Horsman M.R., Khalil A.A., Nordsmark M., Grau C., Overgaard J. Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model. Radiother Oncol. 28:1993;69-71.
20. Horsman M.R., Nordsmark M., Khalil A.A., et al. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Acta Oncol. 33:1994;371-376.
21. Horsman M.R., Siemann D.W., Chaplin D.J., Overgaard J. Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing. Radiother Oncol. 45:1997;167-174.
22. Horsman M.R., Siemann D.W., Nordsmark M., Khalil A.A., Overgaard J., Chaplin D.J. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. Hogan M.C., Mathieu-Costello C., Poole D.C., Wagner P.D. Oxygen transport to tissue XVI. 1994;635-642 Plenum Press, New York, NY.
23. Horsman M.R., Wood P.J., Chaplin D.J., Brown J.M., Overgaard J. The potentiation of radiation damage by nicotinamide in the SCCVII tumor in vivo. Radiother Oncol. 18:1990;49-57.
24. Hoskin P.J., Saunders M.I., Dische S. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer. 86:1999;1322-1328.
25. Inch W.R., McCredie J.A., Sutherland R.M. Effect of duration of breathing 95% oxygen plus 5% carbon dioxide before x-irradiation on cure of C3H mammary tumor. Cancer. 25:1970;926-931.
26. Kaanders J.H.A.M., Bussink J., van der Kogel A.J. ARCON: a novel biology-based approach in radiotherapy. Lancet Oncol. 3:2002;728-737.
27. Kaanders J.H.A.M., Pop L.A.M., Marres H.A.M., et al. ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 52:2002;769-778.
28. 2-histography. Int J Radiat Oncol Biol Phys. 19:1990;953-961.
29. Kimura H., Braun R.D., Ong E.T., et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56:1996;5522-5528.
30. Kjellen E., Joiner M.C., Collier J.M., Johns H., Rojas A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated x-ray treatments. Radiother Oncol. 22:1991;81-91.
31. Kruuv J.A., Inch W.R., McCredie J.A. Blood flow and oxygenation of tumors in mice: I. Effects of breathing gases containing carbon dioxide at atmospheric pressure. Cancer. 20:1967;51-59.
32. Martin L., Lartigau E., Weeger P., et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol. 27:1993;123-130.
33. 2 and radiosensitivity in three tumour lines. Int J Radiat Biol. 65:1994;379-386.
34. Moulder J.E., Rockwell S. Hypoxic fractions in solid tumors. Int J Radiat Oncol Biol Phys. 10:1984;695-712.
35. Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys. 6:1980;1507-1517.
36. Overgaard J., Horsman M.R. Modification of hypoxia induced radioresistance in tumours by the use of oxygen and sensitizers. Semin Radiat Oncol. 6:1996;10-21.
37. Partridge S.E., Aquino-Parsons C., Luo C., Green A., Olive P.L. A pilot study comparing intratumoral oxygenation using the comet assay following 2.5% and 5% carbogen and 100% oxygen. Int J Radiat Oncol Biol Phys. 49:2001;575-580.
38. Powell M.E.B., Collingridge D.R., Saunders M.I., Hoskin P.J., Hill S.A., Chaplin D.J. Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiother Oncol. 50:1999;167-171.
39. Rofstad E.K., Måseide K. Radiobiological and immunochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol. 75:1999;1377-1393.
40. Rojas A., Carl U., Reghebi K. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies. Int J Radiat Oncol Biol Phys. 18:1990;547-553.
41. Rojas A., Hodgkiss R.J., Stratford M.R., Dennis M.F., Johns H. Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with cabogen and nicotinamide: clinical considerations. Br J Cancer. 68:1993;1115-1121.
42. Rubin P., Hanley J., Keys H.M., Marcial V., Brady L. Carbogen breathing during radiation therapy: the Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys. 5:1979;1963-1970.
43. 2) on the in vivo radiation response of a murine sarcoma. Int J Radiat Oncol Biol Phys. 2:1977;903-911.
44. Siemann D.W., Horsman M.R., Chaplin D.J. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiother Oncol. 31:1994;117-122.
45. Siemann D.W., Johansen I.M., Horsman M.R. Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph. Int J Radiat Oncol Biol Phys. 40:1998;1171-1176.
46. Suit H.D., Marshall N., Woerner D. Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma. Cancer. 30:1972;1154-1158.
47. Sutherland R.M., Franko A.J. On the nature of the radiobiologically hypoxic fraction in tumours. Int J Radiat Oncol Biol Phys. 6:1980;117-120.
48. Tannock I.F. The relationship between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer. 22:1968;258-273.
49. Thews O., Kelleher D.K., Vaupel P. Dynamics of tumor oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia. Radiother Oncol. 62:2002;77-85.
50. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 9:1955;539-549.
51. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic micro-environment of human tumors: a review. Cancer Res. 49:1989;6449-6465.